AstraZeneca vaccine hopeful to be green-lighted by EU in January


BRUSSELS, Jan. 12 (Xinhua) -- The European Medicines Agency (EMA) said on Tuesday it had received the application for conditional marketing authorization for a COVID-19 vaccine developed by AstraZeneca and Oxford University, and it could make a recommendation by the end of January through an accelerated procedure.

EMA said in a statement that an opinion on the marketing authorization could be issued during a meeting of EMA's scientific committee for human medicines scheduled for Jan. 29.

Such a short time-frame for evaluation is only possible because EMA has already assessed some data on the vaccine during a rolling review, according to EMA, an authority of the European Union (EU) responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.

Additional scientific information on issues related to quality, safety and efficacy has been provided by the company and is currently being assessed. Four clinical trials are going on in Britain, Brazil and South Africa, said EMA.

So far, the EU has granted authorization of conditional marketing for two vaccines, one jointly developed by Pfizer and BioNTech and the other by Moderna.

As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.

Meanwhile, 236 candidate vaccines are still being developed worldwide -- 63 of them in clinical trials -- in countries including Germany, China, Russia, Britain and the United States, according to information released by WHO on Tuesday.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

Next In World

EU warns it could block vaccine exports, wields legal threat at drugmakers
Protesting Indian farmers locked in stand-off with police near capital
EU set to require authorisation for vaccine exports
Death toll from storm Eloise rises to 21 across southern Africa
Russian court keeps Kremlin critic Navalny in jail despite outcry
Pandemic spurs quest to enroll more Black Americans in vaccine trials
Racing the virus: Why tweaking the vaccines won't be simple
"No end in sight": Portugal's hospitals on brink as COVID cases surge
Russian authorities target ally of Kremlin foe Navalny before jail appeal
Pakistan court frees Islamist convicted of beheading U.S. journalist Daniel Pearl

Stories You'll Enjoy


-->